
CDC’s Assessment of Human Risk of Infection from H5N1
While the current assessment for the U.S. human health risk from avian influenza A (H5N1) remains low, CDC has created a “Risk by Exposure
we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.

While the current assessment for the U.S. human health risk from avian influenza A (H5N1) remains low, CDC has created a “Risk by Exposure

After three recalls of nut-containing products from a Michigan-based distributor within six weeks, the FDA issued a warning letter. The finding noted that food

In a case of interesting timing, less than two weeks after FDA announced the approval of its Human Foods Program reorganization plan, the OIG

Moderna is in Phase 3 of its clinical trial for mRNA-1083, a combined COVID and influenza vaccine. The President of Moderna, Stephen Hoge, announced

We have written before about FSVP being a serious issue, but it is clear that FDA is taking lack of compliance with FSVP very

In its recently published Forward Regulatory Plan: 2024 to 2026 CFIA is taking some positive steps to right some wrongs related to fish inspection

As we experience less severe winters and increasing air temperatures, the risk and range of tick-borne illnesses grow. Historically, very cold, dry winters are

I can never figure out the best way to store meats when I get home from grocery shopping. Should I freeze or refrigerate them?

A year and a half after “reimagining” a newly unified FDA, the agency’s Human Foods Program has been approved by the Department of Health and Human Services (HHS), targeted for Fall 2024 implementation. How will it change the regulation of the food industry?
© 2026 The Acheson Group. All rights reserved